XPH ETF Research - SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (xph)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New ETF | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 97

Threats + Weaknesses = 60

When strengths & opportunities substantially exceed threats & weaknesses an investment in the xph ETF has great long term potential.

ETF Description Update

SPDR S&P Pharmaceuticals ETF (XPH) Description: XPH is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. XPH exchange trading fund (ETF) tracks the S&P Pharma Industry; the s&p pharmaceuticals select industry index represents the pharmaceuticals sub-industry portion of the s&p total markets index. the s&p tmi tracks all the u.s. common stocks listed on the nyse, amex, nsdq national market and nsdq small cap exchanges. the pharmaceuticals index is an equal weighted market cap index. SPDR S&P Pharmaceuticals ETF (XPH) falls under the Health & Biotech Equities category. XPH's dividend yield is roughly 0.89%, it has an expense ratio of 0.35%, and is in the equity ETF asset class. SPDR S&P Pharmaceuticals ETF (XPH) focuses its investments in the U.S. region of the world. XPH does not use leverage and XPH's performance is meant to match its benchmark. The XPH ETF is not affiliated with a particular ETF sector. An investor can find XPH's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features XPH's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on State Street ETF funds or see the ETF research & analysis home page to start.

Portfolio Strategy Update

Be the first to explain SPDR S&P Pharmaceuticals ETF (XPH)'s strategy.

Performance Analysis Update